Loading organizations...
Loading organizations...
Novel anti-cancer therapies reprogramming the tumor microenvironment.
Parthenon Therapeutics has raised $65.0M across 1 funding round.
Parthenon Therapeutics has raised $65.0M in total across 1 funding round.
Parthenon Therapeutics has raised $65.0M in total across 1 funding round.
Parthenon Therapeutics's investors include Northpond Ventures, Taiho Ventures, Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Park West Asset Management, Section 32, Tekla Capital Management.
Parthenon Therapeutics has raised $65.0M across 1 funding round. Most recently, it raised $65.0M Series A in November 2021.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 3, 2021 | $65.0M Series A | Northpond Ventures, Taiho Ventures | Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Park West Asset Management, Section 32, Tekla Capital Management |